BiotechTube

Prochymal® + Placebo + Standard of Care for GVHD

Phase 3Completed
0 watching 0 views this week📈 Rising
72
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Graft Versus Host Disease

Conditions

Graft Versus Host Disease

Trial Timeline

Aug 17, 2006 → May 28, 2009

NCT ID
NCT00366145

About Prochymal® + Placebo + Standard of Care for GVHD

Prochymal® + Placebo + Standard of Care for GVHD is a phase 3 stage product being developed by Mesoblast for Graft Versus Host Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT00366145. Target conditions include Graft Versus Host Disease.

Hype Score Breakdown

Clinical
27
Activity
18
Company
5
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00366145Phase 3Completed

Competing Products

20 competing products in Graft Versus Host Disease

See all competitors
ProductCompanyStageHype Score
Prograf + Methotrexate + CyclosporineAstellas PharmaApproved
85
AlefaceptAstellas PharmaPhase 2
52
tacrolimusAstellas PharmaApproved
85
Tacrolimus + TacrolimusAstellas PharmaPre-clinical
23
azathioprine + sirolimusAstellas PharmaApproved
85
Itolizumab + EQ001 PlaceboBioconPhase 3
77
EQ001 + EQ001 PlaceboBioconPhase 1/2
41
SHR0302Jiangsu Hengrui MedicinePhase 1
33
AcalabrutinibAstraZenecaPhase 2
52
Aspirin + TicagrelorAstraZenecaApproved
85
SugammadexMerckApproved
85
Efprezimod alfa + Methotrexate + Tacrolimus + PlaceboMerckPhase 2
52
RuxolitinibNovartisApproved
85
Imatinib Mesylate and NilotinibNovartisPhase 2
52
Prednisone + Jakavi(ruxolitinib) + PrednisoneNovartisPhase 2
52
PredEverNovartisPhase 2
52
Lifitegrast 5% Ophthalmic Solution + PlaceboNovartisPhase 1
33
CyclosporineNovartisApproved
85
Everolimus + Tacrolimus + Mycophenolic acidNovartisApproved
85
1 + 2NovartisApproved
85

Other Products from Mesoblast

Remestemcel-L + PlaceboPhase 3
72
Remestemcel-LPhase 3
72
Rexlemestrocel-L + HA mixture + SalinePhase 3
72
Infusion of one MPC expanded cord unit and one unexpanded cord unit + Infusion of two unexpanded cord blood units.Phase 3
72
Placebo + PROCHYMAL adult human mesenchymal stem cellsPhase 3
72